 
            IndraLab
Statements
                                      reach
                                
                                  
                                
                                
          
          
                                  "However, because there were too few NSCLC patients with distance metastasis (n = 3) (Table S1) in our group of specimens, no significance was obtained between the correlation of SPATA2 and M classification.Previously, SPATA2 was proved to bind to CYLD and enhance the activity of CYLD."
          
                              
          
                               
                            
                                      sparser
                                
                                  
                                
                                
          
          
                                  "For example, SPATA2 complex with CYLD preferentially deubiquitinating the M1 ubiquitin of RIPK1. xref SPATA2 recruits CYLD to the centrosome for deubiquitination of PLK4, which attenuates NEK7 and NLRP3 interaction and further NLRP3 inflammasome activation. xref SPATA2 activates CYLD to elevate NCOA4 protein level and induces ferroptosis after doxorubicin treatment via preventing its degradation because of reducing the ubiquitination level. xref In consistent with previous reports, in this manuscript, we also found that SPATA2 inhibited β‐catenin signaling via CYLD."
          
                              
          
                               
                            
                                      reach
                                
                                  
                                
                                
          
          
                                  "In 2016, four different groups reported SPATA2 bound to the deubiquitinase cylindromatosis (CYLD) and enhanced CYLD activity, linking SPATA2 to tumor necrosis factor α (TNF‐α) receptor related nuclear factor κB (NF‐κB), nucleotide‐binding oligomerization domain 2 (NOD2) signaling and cell death."